Trade 2 of 73: IN with $1,100

Step 2 of 73 towards turning a thousand into a million is initiated.

On December 26, 2014 I bought 95 shares of EYES at $11.50 per share.

EYES (or Second Sight Medical Products, Inc) is a California-based company that creates retinal prosthesis to provide sight to patients blinded from outer retinal degenerations. In other words, they make the blind see again.

(I hear they wanted to list under symbol JESUS, but Nasdaq turned down the idea.)

At any rate, the company IPO’ed with a bang in November 2014, closing at $24 on the first day of trading, more than doubling its IPO price of $9. The stock has been on decline ever since, and is now trading near its all-time lows.

I have a feeling that a company with a story this good won’t stay low too long. Also, the chart looks like EYES may have found its bottom.

To reach my next ten percent goal of $1,210 I set the sale price at $12.90.

Until then, I hope you have a very happy and prosperous New Year.

Tim H.